Building a predictive model for outcomes with [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer using VISION data: Preliminary results.

Authors

null

Ken Herrmann

Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Ken Herrmann , Andrei Gafita , Johann S. De Bono , A. Oliver Sartor , Kim N. Chi , Bernd J. Krause , Kambiz Rahbar , Scott T. Tagawa , Johannes Czernin , Ghassan El-Haddad , Connie Wong , Zhaojie Zhang , Celine Wilke , Osvaldo Mirante , Michael J. Morris , Karim Fizazi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 208)

DOI

10.1200/JCO.2024.42.4_suppl.208

Abstract #

208

Poster Bd #

J16

Abstract Disclosures